Friday, July 10, 2026
🇺🇸 FDA

Intelligence · INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,798
Companies 1,771
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,798 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Recently updated

FDA-approved

Showing page 20 of 200 · By data quality, then INN

  1. hydrogen peroxide

    ESKATA Aclaris Therapeutics

    TOPICAL FDA: approved

  2. hydroxychloroquine sulfate

    HYDROXYCHLOROQUINE SULFATE Amneal Pharma Europe Ltd

    ORAL FDA: approved

  3. hydroxyzine hydrochloride

    HYDROXYZINE HYDROCHLORIDE Regeneron Ireland Designated Activity Company (DAC)

    INJECTION FDA: approved

  4. hydroxyzine pamoate

    HYDROXYZINE PAMOATE Teva Pharma GmbH

    ORAL FDA: approved

  5. ibandronate sodium

    IBANDRONATE SODIUM Teva Pharma GmbH

    INJECTION FDA: approved

  6. ibandronic acid

    IBANDRONIC ACID SANDOZ Teva Pharma GmbH

    EMA: approved

    M05BA06

  7. ibrutinib

    IMBRUVICA Janssen-Cilag Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    L01EL01

  8. ibuprofen

    APO-IBUPROFEN 400 Lacuna Pharma Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved

    C01EB16

  9. icatibant

    CIPLA ICATIBANT Cipla Australia Pty Ltd

    EMA: approved · TGA: approved

    B06AC02

  10. icatibant acetate

    ICATIBANT ACETATE Takeda

    SUBCUTANEOUS FDA: approved

  11. icosapent ethyl

    VAZKEPA Seqirus (Australia) Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved

    C10AX

  12. idarubicin hydrochloride

    IDARUBICIN HYDROCHLORIDE Teva Pharma GmbH

    INTRAVENOUS FDA: approved

  13. idursulfase

    ELAPRASE Takeda

    IV (INFUSION) FDA: approved · EMA: approved

    A16AB09

  14. ifosfamide

    HOLOXAN BAXTER HEALTHCARE PTY LTD

    INJECTION FDA: approved · TGA: approved

  15. iloperidone

    FANAPTUM Vanda Pharmaceuticals Netherlands B.V.

    ORAL FDA: approved · EMA: unknown

    N05AX14

  16. imatinib

    ARX-IMATINIB Alphapharm Pty Ltd

    EMA: approved · TGA: approved · NMPA: clinical trials

    L01EA01

  17. imatinib mesylate

    IMATINIB MESYLATE Amneal Pharma Europe Ltd

    ORAL FDA: approved

  18. imipramine hydrochloride

    IMIPRAMINE HYDROCHLORIDE Teva Pharma GmbH

    INJECTION FDA: approved

  19. imiquimod

    ALDARA Lacuna Pharma Pty Ltd

    TOPICAL FDA: approved · EMA: approved · TGA: approved

    D06BB10

  20. indapamide

    APO-INDAPAMIDE SR Alphapharm Pty Ltd

    ORAL FDA: approved · TGA: approved

  21. indomethacin

    INDO-LEMMON Amneal Pharma Europe Ltd

    RECTAL FDA: approved · NMPA: clinical trials

  22. influenza mrna vaccine

    MCOMBRIAX Teva Pharma GmbH

    EMA: approved

    J07B

  23. insulin glargine-aldy

    LANGLARA Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    SUBCUTANEOUS FDA: approved

  24. iohexol

    OMNIPAQUE 140 Amneal Pharma Europe Ltd

    ORAL FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,798 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.